Keystone Heart is focused on protecting the brain from emboli to reduce the risk of brain infarcts during TAVR, atrial fibrillation ablation and other structural heart procedures.

Latest News

Share this
News

Join Keystone Heart at EuroPCR 2018!

EuroPCR is coming up May 22-25 in Paris! The global event, hosted by the European Association of Percutaneous Cardiovascular Interventions (EAPCI), is one of our biggest events of the year. Over 12,000 participants come together to network, learn,and innovate.

Over the course of the four days, attendees have the opportunity to attend many educational sessions. It is a great way to stay up to date with the latest techniques, devices, trials,and controversies in cardiovascular medicine.

This year the forum features representatives from over 120 pharmaceutical industry companies. We’re thrilled to be included as an exhibitor again. Each year we look forward to discussions at out booth. We enjoy hearing attendees needs and opinions and using the feedback to make improvements.

If you’ll be attending EuroPCR, please join us at booth F30. We hope to see you there!

For more updates from the event follow us on Facebook, Twitter, and LinkedIn!

Share

No Comments

Leave a reply